Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Protagonist Therapeutics Inc
Today
Create an eToro account to buy PTGX stock on a secure, user-friendly, multi-asset trading platform.
Buy Protagonist Therapeutics Inc
Buy Protagonist Therapeutics Inc
Protagonist Therapeutics Inc PTGX
Buy PTGX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
58
Based on analysts who covered PTGX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-PTGX-Protagonist Therapeutics Inc

Protagonist Therapeutics Inc PTGX

$55.817.45(45.49%)(1D)
• Nasdaq • in USD

PTGX Stock Price Chart

‎43.95‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Protagonist Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Protagonist Therapeutics Inc share price today is $55.8, reflecting a ‎45.49‎% change over the last 24 hours and ‎45.14‎% over the past week. The current market capitalization of PTGX is 2.35B with an average volume in the last three months of 718233.6. The stock has a P/E ratio of 9.12 and a dividend yield of 0%. With the stock’s beta sitting at 1.54
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$2.35B
Day’s Range
i
Shows the high and low prices of the day.
33.66 - 56
52W Range
i
Shows the high and low prices of the last year.
13.59 - 56
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
718233.6
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
9.12
Revenue
i
The total income generated by this company’s goods and services last year.
$434.43M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$38.35
EPS
i
A company’s total earnings divided by the number of shares it has issued.
4.21
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.54
What Is Protagonist Therapeutics Inc?
Protagonist Therapeutics is a healthcare company based in Newark, California, US and established in 1996. Operating locally, the company aims to meet as-yet-unmet medical requirements through the use of peptide drugs. It is traded on the NASDAQ GM under the stock ticker PTGX. PTGX stock is available on eToro. Learn more now!
Buy PTGX

How can I buy Protagonist Therapeutics Inc stocks?

To purchase Protagonist Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Protagonist Therapeutics Inc (PTGX) page and place an order to buy Protagonist Therapeutics Inc.
Buy PTGX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Protagonist Therapeutics Inc
Invest in Protagonist Therapeutics Inc
Today
Create an eToro account to buy PTGX stock on a secure, user-friendly, multi-asset trading platform.
Buy PTGX

FAQ

The current price of PTGX is $55.8.
The average price target for Protagonist Therapeutics Inc is $55.8. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Protagonist Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Protagonist Therapeutics Inc is $2.35B
Daily Movers
Explore the biggest stocks movers on the market.
Buy PTGX
Scroll to top